alexa In-vitro Antifilarial Screening Of Lawsonia Inermis Extracts Against Experimental Filarial Infections | 14008
ISSN: 2167-0501

Biochemistry & Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

International Conference on Pharmacognosy, Phytochemistry & Natural Products

S. K. Lanjhiyana and Sweety Lanjhiyana
Accepted Abstracts: Biochem & Pharmacol
DOI: 10.4172/2167-0501.S1.004
Abstract
Lymphatic filariasis is considered endemic especially in tropical and subtropical regions of developing countries. More than 120 million populations around the world are infected whereas more than one billion people at risk of infection. Recommended combination therapies of broad-spectrum doses of either ivermectin with albendazole or albendazole with diethylcarbamazine are potential for microfilaricides only but having no effect on the adult macroflariae. Hence, it is essential to develop and effective phyto-medicine based antifilarial drug having potential to kill or permanently sterilize the adult worm with comparatively no side effect on other hand. Dried chopped leaves of Lawsonia inermis (Family: Lythraceae) were subjected to soxhletion for methanolic (MLE) and aqueous (ALE) extracts. The bio-assay guided fractions of MLE & ALE obtained after column chromatography was subjected to in-vitro screening for worm motility and nerve muscle preparation assay against adult bovine filarial S. digitata parasite. After incubation for 24 and 48 h respectively at dose concentration of 0.01 to 1.0 mg/ml for possible dose response relationship thereby confirmed for irreversible-paralysis of both male and female worms was found to be significant (P<0.05) effect. Present study was focused to explore possible phyto-fractions based macrofilaricidal drug for treatment of human filariasis by using in-vitro and thereafter for in-vivo screening methodology.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7